Related Experiment Video
Updated: May 13, 2026
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Prediction of cancer outcome using DNA microarray technology: past, present and future
Olivier Gevaert1, Bart De Moor
1Katholieke Universiteit Leuven, Department of Electrical Engineering ESAT-SCD-Sista, Kasteelpark Arenberg 10, 3001 Leuven, Belgium +32 16 328646 ; +32 16 32 ; olivier.gevaert@esat.kuleuven.be.
Expert Opinion on Medical Diagnostics
|March 15, 2013
Summary
DNA microarray and other omics technologies show promise for predicting cancer outcomes. Integrating multiple omics data may improve predictions, but further validation studies are needed to confirm their effectiveness.
Area of Science:
- Oncology
- Genomics
- Biotechnology
Background:
- DNA microarray technology has been used for nearly a decade to predict cancer outcomes, yet individualized therapy remains elusive.
- Emerging omics technologies also show potential for improving cancer patient outcome prediction.
Purpose of the Study:
- To investigate the impact of DNA microarray and other omics technologies on cancer outcome prediction.
- To determine if integrating omics data enhances predictive accuracy.
Main Methods:
- Focused on DNA microarray technology as the most mature omics approach.
- Described emerging omics technologies with potential for outcome prediction.
Main Results:
- Various omics technologies, beyond DNA microarrays, demonstrate promise in predicting cancer outcomes.
- Integration of multiple omics data appears to improve predictive performance.
Conclusions:
- Emerging omics technologies may offer alternatives or improvements to DNA microarrays for cancer outcome prediction.
- While integrating omics data shows potential for better predictions, comprehensive validation studies are necessary.
- Further research is required to identify the most informative omics data and optimal combinations for predictive accuracy.
Related Concept Videos
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...